In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Inari Medical Inc (NASDAQ: NARI) closed at $38.18 up 2.88% from its previous closing price of $37.11. In other words, the price has increased by $2.88 from its previous closing price. On the day, 1.37 million shares were traded. NARI stock price reached its highest trading level at $39.23 during the session, while it also had its lowest trading level at $37.08.
Ratios:
For a deeper understanding of Inari Medical Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.07 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 70.88. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 3.09. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on February 29, 2024, Downgraded its rating to Neutral and sets its target price to $55 from $85 previously.
On January 23, 2024, Needham started tracking the stock assigning a Buy rating and target price of $72.
On July 19, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $79.Robert W. Baird initiated its Outperform rating on July 19, 2023, with a $79 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 16 ’24 when Hoffman William sold 1,451 shares for $40.00 per share. The transaction valued at 58,040 led to the insider holds 999,782 shares of the business.
Hill, Mitch C. sold 6,000 shares of NARI for $245,760 on Apr 12 ’24. The Chief Financial Officer now owns 181,294 shares after completing the transaction at $40.96 per share. On Mar 18 ’24, another insider, Hoffman William, who serves as the Director of the company, sold 40,000 shares for $41.13 each. As a result, the insider received 1,645,079 and left with 1,003,296 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NARI now has a Market Capitalization of 2212935680 and an Enterprise Value of 2129528960. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.48 while its Price-to-Book (P/B) ratio in mrq is 4.74. Its current Enterprise Value per Revenue stands at 4.314 whereas that against EBITDA is 1087.604.
Stock Price History:
Over the past 52 weeks, NARI has reached a high of $71.85, while it has fallen to a 52-week low of $36.73. The 50-Day Moving Average of the stock is -17.46%, while the 200-Day Moving Average is calculated to be -33.58%.
Shares Statistics:
For the past three months, NARI has traded an average of 1.20M shares per day and 999890 over the past ten days. A total of 57.76M shares are outstanding, with a floating share count of 49.59M. Insiders hold about 14.45% of the company’s shares, while institutions hold 87.07% stake in the company. Shares short for NARI as of 1711584000 were 3990583 with a Short Ratio of 3.33, compared to 1709164800 on 5048858. Therefore, it implies a Short% of Shares Outstanding of 3990583 and a Short% of Float of 8.7299995.
